Immediate Impact

52 standout
Sub-graph 1 of 23

Citing Papers

Oesophageal cancer
2024 Standout
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
2023 Standout
3 intermediate papers

Works of Eva Fernebro being referenced

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
2013
Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Eva Fernebro 585 166 181 231 203 28 826
Wesley O. Greaves 371 111 149 347 215 24 844
Andrea Mancuso 426 82 118 198 291 35 710
Arturo Loaiza‐Bonilla 508 151 74 284 232 53 915
Shu Tian 370 127 112 237 252 21 726
R.J. Salmon 456 89 230 187 98 22 780
Nobuyoshi Momiyama 421 121 128 363 152 33 902
Marco Losa 451 104 143 324 241 19 787
Robert J. Behrens 472 134 177 203 141 39 789
Casey W. Williamson 364 141 91 296 201 30 894
Mónica Musteanu 541 107 74 392 142 31 930

All Works

Loading papers...

Rankless by CCL
2026